Hypogonadotropic Hypogonadism

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue 2, 2007, Pages 283-296

  Layman, Lawrence C ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Institute of Molecular Medicine and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; GENE PRODUCT; GONADORELIN; GONADORELIN RECEPTOR; GONADOTROPIN; PROTEIN KAL1; TESTOSTERONE; UNCLASSIFIED DRUG;

AGE; CELL MIGRATION; CHILDHOOD; DRUG INDICATION; EMBRYO DEVELOPMENT; FGFR1 GENE; GENE; GENE MUTATION; GNRHR GENE; GONADOTROPIN BLOOD LEVEL; HEREDITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; KAL1 GENE; MALE; MALE FERTILITY; NERVE CELL; OLFACTORY NERVE; OLFACTORY PLACODE; PRIORITY JOURNAL; PUBERTY; REVIEW; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL;

ALGORITHMS; CHROMOSOME ABERRATIONS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NERVE TISSUE PROTEINS; PITUITARY-ADRENAL SYSTEM; PUBERTY, DELAYED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, LHRH; SEX CHROMOSOMES;

EID: 34249724409     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.03.010     Document Type: Review

References (39)

1. Wierman M.E., Pawlowski J.E., Allen M.P., et al. Molecular mechanisms of gonadotropin-releasing hormone neuronal migration. Trends Endocrinol Metab 15 3 (2004) 96-102
2. Grumbach M.M. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90 5 (2005) 3122-3127
3. Crowley Jr. W., Filicori M., Spratt D., et al. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41 (1985) 473-531
4. Layman L.C., and Reindollar R.H. The diagnosis and treatment of pubertal disorders. Adolescent Medicine: State of the Art Reviews 5 (1994) 37-55
5. Reindollar R.H., Byrd J.R., and McDonough P.G. Delayed sexual development: study of 252 patients. Am J Obstet Gynecol 140 (1981) 371-380
6. Wit J.M., Vulsma T., and de Vijlder J.J. [From gene to disease; POU1F1- and PROP1-mutations in pituitary hormone deficiency]. Ned Tijdschr Geneeskd 145 50 (2001) 2425-2427 [in Dutch]
7. Burris A.S., Rodbard H.W., Winters S.J., et al. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 66 (1988) 1144-1151
8. Bhagavath B., Podolsky R.H., Ozata M., et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil Steril 85 3 (2006) 706-713
9. Layman L.C. Human gene mutations causing infertility. J Med Genet 39 3 (2002) 153-161
10. Dode C., Levilliers J., Dupont J.M., et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33 4 (2003) 463-465
11. Pitteloud N., Acierno Jr. J.S., Meysing A., et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A 103 16 (2006) 6281-6286
12. Sato N., Katsumata N., Kagami M., et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab 89 3 (2004) 1079-1088
13. Albuisson J., Pecheux C., Carel J.C., et al. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat 25 1 (2005) 98-99
14. Bhagavath B., Ozata M., Ozdemir I.C., et al. The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism. Fertil Steril 84 4 (2005) 951-957
15. Franco B., Guioli S., Pragliola A., et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353 (1991) 529-536
16. Legouis R., Hardelin J., Levilliers J., et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67 (1991) 423-435
17. Hardelin J.P., Levilliers J., Blanchard S., et al. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum Mol Genet 2 4 (1993) 373-377
18. Bick D., Franco B., Sherins R.S., et al. Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med 326 (1992) 1752-1755
19. Georgopoulos N.A., Pralong F.P., Seidman C.E., et al. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 82 1 (1997) 213-217
20. Rugarli E., and Ballabio A. Kallmann syndrome from genetics to neurobiology. JAMA 270 (1993) 2713-2716
21. Lutz B., Karatani S., Rugarli E.I., et al. Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo. Hum Mol Genet 3 10 (1994) 1717-1723
22. Soussi-Yanicostas N., de Castro F., Julliard A.K., et al. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 109 2 (2002) 217-228
23. Pitteloud N., Meysing A., Quinton R., et al. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 254-5 (2006) 60-69
24. Howard P.W., and Maurer R.A. A point mutation in the LIM domain of Lhx3 reduces activation of the glycoprotein hormone alpha-subunit promoter. J Biol Chem 276 22 (2001) 19020-19026
25. Dattani M.T., Martinez-Barbera J.-P., Thomas P.Q., et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19 (1998) 125-133
26. Wu W., Cogan J.D., Pfaffle R.W., et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18 (1998) 147-149
27. Pitteloud N., Hayes F.J., Boepple P.A., et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87 1 (2002) 152-160
28. Barrio R., de Luis D., Alonso M., et al. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril 71 2 (1999) 244-248
29. Burgues S., and Calderon M.D. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod 12 5 (1997) 980-986
30. D'Agata R., Heindel J.J., Vicari E., et al. hCG-induced maturation of the seminiferous epithelium in hypogonadotropic men. Horm Res 19 1 (1984) 23-32
31. Jones T.H., and Darne J.F. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 38 2 (1993) 203-208
32. Kliesch S., Behre H.M., and Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril 63 6 (1995) 1326-1328
33. Ley S.B., and Leonard J.M. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 61 4 (1985) 746-752
34. Liu L., Banks S.M., Barnes K.M., et al. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 67 6 (1988) 1140-1145
35. Schopohl J. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Hum Reprod 8 Suppl 2 (1993) 175-179
36. Schopohl J., Mehltretter G., von Zumbusch R., et al. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril 56 6 (1991) 1143-1150
37. Weinstein R.L., and Reitz R.E. Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism. J Clin Invest 53 2 (1974) 408-415
38. Bhasin S., Cunningham G.R., Hayes F.J., et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91 6 (2006) 1995-2010
39. Nachtigall L.B., Boepple P.A., Pralong F.P., et al. Adult-onset idiopathic hypogonadotropic hypogonadism-a treatable form of male infertility. N Engl J Med 336 6 (1997) 410-415